HARTIS Pharma is a Swiss biotech focusing on unmet or non adequately addressed medical needs through revisiting the therapeutic potentials of high density lipoprotein (HDL), especially via regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants.